To elucidate cellular mechanisms of insulin resistance induced by exce
ss dietary fat, we studied conscious chronically high-fat-fed (HFF) an
d control chow diet-fed rats during euglycemic-hyperinsulinemic (560 p
mol/l plasma insulin) clamps. Compared with chow diet feeding, fat fee
ding significantly impaired insulin action (reduced whole body glucose
disposal rate, reduced skeletal muscle glucose metabolism, and decrea
sed insulin suppressibility of hepatic glucose production [HGP]). In H
FF rats, hyperinsulinemia significantly suppressed circulating free fa
tty acids but not the intracellular availability of fatty acid in skel
etal muscle (long chain fatty acyl-CoA esters remained at 230% above c
ontrol levels). In HFF animals, acute blockade of beta-oxidation using
etomoxir increased insulin-stimulated muscle glucose uptake, via a se
lective increase in the component directed to glycolysis, but did not
reverse the defect in net glycogen synthesis or glycogen synthase. In
clamp HFF animals, etomoxir did not significantly alter the reduced ab
ility of insulin to suppress HGP, but induced substantial depletion of
hepatic glycogen content. This implied that gluconeogenesis was reduc
ed by inhibition of hepatic fatty acid oxidation and that an alternati
ve mechanism was involved in the elevated HGP in HFF rats. Evidence wa
s then obtained suggesting that this involves a reduction in hepatic g
lucokinase (GK) activity and an inability of insulin to acutely lower
glucose-6-phosphatase (G-6-Pase) activity. Overall, a 76% increase in
the activity ratio G-6-Pase/GK was observed, which mould favor net hep
atic glucose release and elevated HGP in HFF rats. Thus in the insulin
-resistant HFF rat 1) acute hyperinsulinemia fails to quench elevated
muscle and liver lipid availability, 2) elevated lipid oxidation oppos
es insulin stimulation of muscle glucose oxidation (perhaps via the gl
ucose-fatty acid cycle) and suppression of hepatic gluconeogenesis, an
d 3) mechanisms of impaired insulin-stimulated glucose storage and HGP
suppressibility are not dependent on concomitant Lipid oxidation; in
the case of HGP we provide evidence for pivotal involvement of G-6-Pas
e and GK in the regulation of HGP by insulin, independent of the gluco
se source.